Curis Inc (NASDAQ:CRIS)

2.54
Delayed Data
As of Mar 27
 -0.04 / -1.55%
Today’s Change
1.09
Today|||52-Week Range
3.50
+69.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$273.9M

Company Description

Curis, Inc. is a drug development company, which is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. The company conducts research programs both internally and through strategic collaborations. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Contact Information

Curis, Inc.
4 Maguire Road
Lexington Massachusetts 02421
P:(617) 503-6500
Investor Relations:
(617) 503-6605

Employees

Shareholders

Mutual fund holders7.53%
Other institutional43.67%
Individual stakeholders23.75%

Top Executives

Ali FattaeyPresident, Chief Executive Officer & Director
Michael P. GrayCFO, Secretary, Treasurer & Chief Business Officer
Jaye VinerChief Medical Officer & Executive Vice President
Mark W. NoelVP-Technology Management & Intellectual Property
Tania ChanderVice President-Product Development

To view my watchlist

Not a member yet?

Sign up now for a free account